As retailers and manufacturers of consumer products sold in the United States adapt to the business realities of COVID-19, many have targeted their efforts toward sales of products such as masks and sanitizers that have seen demand skyrocket. With this comes the sometimes previously-uncharted territory of regulated products and increased awareness around product labeling, advertising and marketing.
The U.S. Food and Drug Administration (FDA) and Federal Trade Commission (FTC) continue to enforce regulatory regimes to protect consumers from unapproved or potentially misleading products. Retailers and manufacturers of consumer products should proceed with caution and ensure that any products they are selling comply with FDA and other regulations, and strive for accuracy in advertising and marketing to reduce the risk of enforcement actions, warning letters or consumer claims.
The U.S. Food and Drug Administration (FDA) and the Federal Trade Commission (FTC) issued warning letters to seven companies for selling fraudulent COVID-19 products. These products are unapproved drugs that pose significant risks to patient health and violate federal law [. . . .] “The FDA considers the sale and promotion of fraudulent COVID-19 products to be a threat to the public health [. . . .] We’re prepared to take enforcement actions against companies that continue to market this type of scam.”